10 min listen
Doug Drysdale, CEO, Cybin
ratings:
Length:
20 minutes
Released:
Sep 15, 2021
Format:
Podcast episode
Description
In today’s episode of the Psychedelic Spotlight podcast, we sit down with Doug Drysdale, CEO of Cybin, a biotechnology company focused on creating new, effective, and accessible psychedelic-based therapies.In our conversation, Doug talks about the company’s mission to revolutionize mental healthcare, how Cybin is delivering powerful and effective therapies, and why being the first psychedelic-based company to list on the New York Stock Exchange was a natural fit. Cybin can be found on the NYSE under the ticker symbol $CYBN.*To learn more about Cybin and the work they’re doing, visit their website: Cybin.com*Subscribe to our newsletter to get the latest industry news: PsychedelicSpotlight.comInstagram: @PsycSpotlightTwitter: @PsycSpotlightFacebook: PsychedelicSpotlightYouTube: PsychedelicSpotlightLinkedIn: Psychedelic-Spotlight*This interview was recorded on September 2, 2021.
Released:
Sep 15, 2021
Format:
Podcast episode
Titles in the series (100)
Ronan Levy, Field Trip Health: Global Trac Solutions, Inc., CEO, David Flores, sits down with Field Trip Health, Founder & Executive Chairman, Ronan Levy. by Psychedelic Spotlight Podcast